Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
3D Genomemedicine Inc is going to operate in USA
Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.
Visit us at MEDICA in Duesseldorf, Germany:
15.11. - 18.11.21
Visit us at Jefferies Virtual London Healthcare Conference, UK:
17.11. - 19.11.21
Visit us at INVEST in Stuttgart, Germany:
23.03. - 24.04.21
Visit us at LSX World Congress 2021 Virtual London, UK:
01.02 - 05.02.2021
Visit us at Investival Showcase Virtual London, UK:
11.11. - 16.11.20
|Name of ready to use
|SUD4||Genekam S Immune T: Ready to use kit for in vitro immunisation of human B-lymphocytes of peripheral blood against toxic targers||call|